Johnson & Johnson (JNJ) operating KPIs
JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3043% above fair value
$273.20−2.00 (-0.73%)
Close on Oct 30, 2026Market cap $658.38BP/E 31.7Yield 1.88%
Johnson & Johnson over-the-Counter (OTC) Medicines (TYLENOL, MOTRIN, ZYRTEC) — International sales ($M) ($M)
Form 10-Q / 10-K Segment Note & Form 8-K EX-99.2 Segment Sales Schedule
Latest, FY2022
3,249
Period ended Jan 1, 2023
Change on a year earlier
+7.1%
3,034 in FY2021
History
7 years
Since FY2016
Sources
4
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Over-the-Counter (OTC) Medicines (TYLENOL, MOTRIN, ZYRTEC) — International sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2022 | Jan 1, 2023 | 3,249 | +7.1% | Form 10-K (filed 2023-02-16) ↗ |
| FY2021 | Jan 2, 2022 | 3,034 | +9.9% | Form 10-K (filed 2023-02-16) ↗ |
| FY2020 | Jan 3, 2021 | 2,761 | +13.4% | Form 10-K (filed 2023-02-16) ↗ |
| FY2019 | Dec 29, 2019 | 2,434 | -2.0% | Form 10-K (filed 2022-02-17) ↗ |
| FY2018 | Dec 30, 2018 | 2,484 | +3.1% | Form 10-K (filed 2021-02-22) ↗ |
| FY2017 | Dec 31, 2017 | 2,410 | +4.7% | Form 10-K (filed 2019-02-20) ↗ |
| FY2016 | Jan 1, 2017 | 2,302 | – | Form 10-K (filed 2019-02-20) ↗ |
Breakdown
What makes up over-the-counter (otc) medicines (tylenol, motrin, zyrtec) — international sales ($m)
Cite this data
StockData. (2026). Johnson & Johnson Over-the-Counter (OTC) Medicines (TYLENOL, MOTRIN, ZYRTEC) — International sales ($M) ($M), annual FY2016–FY2022 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/ch_otc_intl
See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.